IntroductionHematological malignancies, such as leukemias, lymphomas, and multiple myeloma, are a heterogeneous group of cancers that arise in the bone marrow and lymphatic system. Conventional trea...
hematological-malignancies
IntroductionCancer is still one of the most difficult diseases to cure, and conventional treatments such as chemotherapy, radiation, and surgery have yielded limited success and severe side effects....
hematological-malignancies
The rise of CAR T Cell therapy in ChinaChina's journey with CAR T-cell therapy began in 2013 with the first clinical trials. Since then, the country has witnessed an exponential growth in this field, ...
hematological-malignancies